Middle East & Africa Duodenal Ulcer Treatment Market Size & Outlook

The duodenal ulcer treatment market in Middle East & Africa is expected to reach a projected revenue of US$ 181.1 million by 2030. A compound annual growth rate of 2% is expected of Middle East & Africa duodenal ulcer treatment market from 2025 to 2030.
Revenue, 2024 (US$M)
$160.5
Forecast, 2030 (US$M)
$181.1
CAGR, 2025 - 2030
2%
Report Coverage
Middle East & Africa

To keep accessing Horizon, please sign in or register for a free account

  • Access to global market statistics
  • Access to company profiles
  • Free use-cases & research insights

No credit card required*

Middle East & Africa duodenal ulcer treatment market, 2018-2030 (US$M)

To keep accessing Horizon, please sign in or register for a free account

  • Access to global market statistics
  • Access to company profiles
  • Free use-cases & research insights

No credit card required*

MEA duodenal ulcer treatment market highlights

  • The MEA duodenal ulcer treatment market generated a revenue of USD 160.5 million in 2024.
  • The market is expected to grow at a CAGR of 2% from 2025 to 2030.
  • In terms of segment, proton pump inhibitors was the largest revenue generating treatment in 2024.
  • Antibiotics is the most lucrative treatment segment registering the fastest growth during the forecast period.
  • Country-wise, Kuwait is expected to register the highest CAGR from 2025 to 2030.

MEA data book summary

Market revenue in 2024USD 160.5 million
Market revenue in 2030USD 181.1 million
Growth rate2% (CAGR from 2025 to 2030)
Largest segmentProton pump inhibitors
Fastest growing segmentAntibiotics
Historical data covered2018 - 2023
Base year for estimation2024
Forecast period covered2025 - 2030
Quantitative unitsRevenue in USD million
Market segmentationProton Pump Inhibitors, H2 Antagonists, Antibiotics, Other
Key market players worldwideGSK PLC, Pfizer Inc, Abbott Laboratories, Merck KGaA, Novartis AG ADR, Bristol-Myers Squibb Co, AstraZeneca PLC, Takeda Pharmaceutical Co Ltd, Eisai Co Ltd

Other key industry trends

  • In terms of revenue, MEA region accounted for 3.5% of the global duodenal ulcer treatment market in 2024.
  • Globally, North America is projected to lead the regional market in terms of revenue in 2030.
  • Asia Pacific is the fastest growing regional market and is projected to reach USD 1,368.4 million by 2030.

No credit card required*

Horizon in a snapshot

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more

Duodenal Ulcer Treatment Market Companies

Name Profile # Employees HQ Website
Eisai Co Ltd View profile 11076 4-6-10 Koishikawa, Bunkyo-ku, Tokyo, Japan, 112-8088 http://www.eisai.co.jp
Takeda Pharmaceutical Co Ltd View profile 49095 1-1, Nihonbashi-Honcho 2-Chome, Chuo-ku, Tokyo, Japan, 103-8668 https://www.takeda.com
AstraZeneca PLC View profile 89900 1 Francis Crick Avenue, Cambridge Biomedical Campus, Cambridge, United Kingdom, CB2 0AA https://www.astrazeneca.com
GSK PLC View profile 70200 980 Great West Road, Brentford, Middlesex, United Kingdom, TW8 9GS https://www.gsk.com
Bristol-Myers Squibb Co View profile 34100 Route 206 and Province Line Road, Princeton, New Jersey, NJ, United States, 08543 https://www.bms.com
Pfizer Inc View profile 88000 66 Hudson Boulevard East, New York, NY, United States, 10001-2192 https://www.pfizer.com
Abbott Laboratories View profile 114000 100 Abbott Park Road, Abbott Park, IL, United States, 60064-6400 https://www.abbottinvestor.com
Merck KGaA View profile 62345 Frankfurter Strasse 250, Darmstadt, HE, Germany, 64293 https://www.emdgroup.com
Novartis AG ADR View profile 76057 Lichtstrasse 35, Basel, Switzerland, 4056 https://www.novartis.com

Middle East & Africa duodenal ulcer treatment market outlook

The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to duodenal ulcer treatment market will help companies and investors design strategic landscapes.


Proton pump inhibitors was the largest segment with a revenue share of 53.08% in 2024. Horizon Databook has segmented the Middle East & Africa duodenal ulcer treatment market based on proton pump inhibitors, h2 antagonists, antibiotics, other covering the revenue growth of each sub-segment from 2018 to 2030.


Reasons to subscribe to Middle East & Africa duodenal ulcer treatment market databook:

  • Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
  • Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
  • Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
  • Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
  • Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.

Target buyers of Middle East & Africa duodenal ulcer treatment market databook

  • Our clientele includes a mix of duodenal ulcer treatment market companies, investment firms, advisory firms & academic institutions.
  • 30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
  • Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
  • The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.

Horizon Databook provides a detailed overview of continent-level data and insights on the Middle East & Africa duodenal ulcer treatment market , including forecasts for subscribers. This continent databook contains high-level insights into Middle East & Africa duodenal ulcer treatment market from 2018 to 2030, including revenue numbers, major trends, and company profiles.

Partial client list

  • logo

MEA duodenal ulcer treatment market size, by country, 2018-2030 (US$M)

Middle East & Africa Duodenal Ulcer Treatment Market Outlook Share, 2024 & 2030 (US$M)

MEA duodenal ulcer treatment market size, by country, 2018-2030 (US$M)

Sign up - it's easy, and free!

Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our free plan indefinitely.

Explore all plans

Included in Horizon account

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more
Chat with us
Research Assistance
Online